$0.80
7.86% today
Nasdaq, Apr 04, 07:45 pm CET
ISIN
US60855D1019
Symbol
MBRX
Sector
Industry

Moleculin Biotech, Inc. Target price 2025 - Analyst rating & recommendation

Moleculin Biotech, Inc. Classifications & Recommendation:

Buy
100%

Moleculin Biotech, Inc. Price Target

Target Price $10.67
Price $0.87
Potential
Number of Estimates 3
3 Analysts have issued a price target Moleculin Biotech, Inc. 2026 . The average Moleculin Biotech, Inc. target price is $10.67. This is higher than the current stock price. The highest price target is
$20.00 2,202.29%
register free of charge
, the lowest is .
A rating was issued by 3 analysts: 3 Analysts recommend Moleculin Biotech, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Moleculin Biotech, Inc. stock has an average upside potential 2026 of . Most analysts recommend the Moleculin Biotech, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -6.32 -1.36
58.06% 78.48%
P/E negative

1 Analysts have issued a Moleculin Biotech, Inc. forecast for earnings per share. The average Moleculin Biotech, Inc. EPS is

$-1.36
Unlock
. This is
80.90% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-1.36 80.90%
Unlock
, the lowest is
$-1.36 80.90%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-6.32 58.06%
2025
$-1.36 78.48%
Unlock
2026
$-1.47 8.09%
Unlock
2027
$-1.31 10.88%
Unlock
2028
$-1.18 9.92%
Unlock
2029
$0.82 169.49%
Unlock

P/E ratio

Current -0.12 69.23%
2025
-0.64 433.33%
Unlock
2026
-0.59 7.81%
Unlock
2027
-0.66 11.86%
Unlock
2028
-0.74 12.12%
Unlock
2029
1.06 243.24%
Unlock

Current Moleculin Biotech, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
Locked
Locked Mar 25 2025
Maxim Group
Locked
Locked
Locked Mar 25 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 24 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 03 2025
Maxim Group
Locked
Locked
Locked Nov 12 2024
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 25 2025
Locked
Maxim Group:
Locked
Locked
Mar 25 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 24 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 03 2025
Locked
Maxim Group:
Locked
Locked
Nov 12 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today